Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05831787 · OUTCOME

Feasibility of Obtaining Baseline Clinical and PRO Data Capture From 200 Consented Patients.

COVID19 OutcomeS in Myeloma and the Impact of VaCcines · Source last updated 2026-05-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
At Baseline

What was measured

Proportion of consented participants who provide responses for the PRO instruments \& proportion of participants who permission access to clinical data through the EHR.

Groups in this outcome

Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease

Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease200

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease196Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        196
denoms
  1. counts
    1. group Id
      OG000
      value
      200
    units
    Participants
description
Proportion of consented participants who provide responses for the PRO instruments \& proportion of participants who permission access to clinical data through the EHR.
groups
  1. description
    Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.
    id
    OG000
    title
    Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
At Baseline
title
Feasibility of Obtaining Baseline Clinical and PRO Data Capture From 200 Consented Patients.
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice